SCHEMBL12468314

SCHEMBL12468314

CCCCCc1nc(C=O)c(S(=O)(=O)c2ccccc2)[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.42
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
GPR84 Q9NQS5 5/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
XBP1 P17861 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ABCB1 P08183 1/20 0.38
HIF1A Q16665 1/20 0.37
EPAS1 Q99814 1/20 0.37
SAE1 Q9UBE0 1/20 0.37
UBA2 Q9UBT2 1/20 0.37
CCNE2 O96020 1/20 0.37
CCNE1 P24864 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL725665 0.73 PTGDR2 (0.35) PARP1GPR84ABCB1
SCHEMBL3728620 0.70 GPR84 (0.45) PARP1GPR84HIF1AEPAS1
SCHEMBL16111391 0.69 TDP1 (0.40) CA2GPR84ABCB1
SCHEMBL2550482 0.68 AGTR1 (0.42) GPR84LMNAHTTSMN1; SMN2
SCHEMBL3735333 0.67 PARP1 (0.43) PARP1GPR84HIF1AEPAS1
SCHEMBL9195142 0.66 PARP1 (0.47) PARP1LMNAMAPTSMN1; SMN2
SCHEMBL2454194 0.65 PARP1 (0.42) PARP1CA12CA1CA2CA9
SCHEMBL28954365 0.65 CA2 (0.62) CA12CA1CA2CA9LMNA
SCHEMBL9123535 0.65 PARP1 (0.42) PARP1GPR84HIF1A
SCHEMBL5858591 0.65 POLB (0.69) PARP1LMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012027481-A9 COMPOUNDS FOR TREATMENT OF CANCER GTX, INC. (US) 2013-10-10 WO disclosed
EP-2608671-A1 COMPOUNDS FOR TREATMENT OF CANCER Gtx, Inc. (US) 2013-07-03 EP disclosed
EP-2542081-A1 COMPOUNDS FOR TREATMENT OF CANCER Gtx, Inc. (US) 2013-01-09 EP disclosed
WO-2012027481-A1 COMPOUNDS FOR TREATMENT OF CANCER GTX, INC. (US) 2012-03-01 WO disclosed